Comparison between binocular indirect ophthalmoscopy and digital retinography for diabetic retinopathy screening: The multicenter Brazilian Type 1 Diabetes Study

Diabetology and Metabolic Syndrome

Volumn 7, Issue 1, 2015, Pages

  Malerbi, Fernando Korn ^a   Morales, Paulo Henrique ^a   Farah, Michel Eid ^a   Drummond, Karla Rezende Guerra ^b   Mattos, Tessa Cerqueira Lemos ^c   Pinheiro, André Araújo ^d   Mallmann, Felipe ^e   Perez, Ricardo Vessoni ^f   Leal, Franz Schubert Lopes ^g   Gomes, Marília Brito ^h   Dib, Sergio Atala ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b Hospital Federal dos Servidores do Estado   (Brazil)

^c Centro de Diabetes e Endocrinologia da Bahia   (Brazil)

^d Hospital Regional de Taguatinga   (Brazil)

^e FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^f UNIVERSITY OF SÃO PAULO   (Brazil)

^g UNIVERSITY OF CAMPINAS   (Brazil)

^h STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Blindness; Diabetic retinopathy; Retinography; Screening; Telemedicine

Indexed keywords

ADULT; ARTICLE; BINOCULAR INDIRECT OPHTHALMOSCOPY; BRAZILIAN; CAMERA; CLINICAL OBSERVATION; CONTROLLED STUDY; DIABETIC RETINOPATHY; DIAGNOSTIC TEST ACCURACY STUDY; DIGITAL RETINOGRAPHY; FEMALE; HUMAN; INDIRECT OPHTHALMOSCOPE; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MYDRIASIS; OPHTHALMOSCOPY; PATIENT REFERRAL; PRIORITY JOURNAL; RETINOGRAPHY; SCREENING; TELEMEDICINE;

EID: 84955390282     PISSN: None     EISSN: 17585996     Source Type: Journal    
DOI: 10.1186/s13098-015-0110-8     Document Type: Article

References (45)

1. Zheng Y, He M, Congdon N. The worldwide epidemic of diabetic retinopathy. Indian J Ophthalmol. 2012;60:428-31.
2. Yau JW, Rogers SL, Kawasaki R, Lamoureux EL, Kowalski JW, Bek T, et al. Meta-Analysis for Eye Disease (META-EYE) Study Group. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care. 2012;35:556-64.
3. Li R, Zhang P, Barker LE, Chowdhury FM, Zhang X. Cost-effectiveness of interventions to prevent and control diabetes mellitus: a systematic review. Diabetes Care. 2010;33:1872-94.
4. Au A, Gupta O. The economics of telemedicine for vitreoretinal diseases. Curr Opin Ophthalmol. 2011;22:194-8.
5. Stefánsson E. Prevention of diabetic blindness. Br J Ophthalmol. 2006;90:2-3.
6. Looker HC, Nyangoma SO, Cromie DT, Olson JA, Leese GP, Black MW, et al. On behalf of the Scottish Diabetes Research Network Epidemiology Group and the Scottish Diabetic Retinopathy Collaborative. Rates of referable eye disease in the Scottish National Diabetic Retinopathy Screening Programme. Br J Ophthalmol. 2014;98:790-5.
7. Forster AS, Forbes A, Dodhia H, Connor C, Du Chemin A, Sivaprasad S, et al. Changes in detection of retinopathy in type 2 diabetes in the first 4 years of a population-based diabetic eye screening program. Diabetes Care. 2013;36:2663-9.
8. Hautala N, Aikkila R, Korpelainen J, Keskitalo A, Kurikka A, Falck A, et al. Marked reductions in visual impairment due to diabetic retinopathy achieved by efficient screening and timely treatment. Acta Ophthalmol. 2014;92:582-7.
9. Agardh E, Agardh CD, Hansson-Lundblad C. The five-year incidence of blindness after introducing a screening programme for early detection of treatable diabetic retinopathy. Diabet Med. 1993;10:555-9.
10. Wilkinson CP, Ferris FL III, Klein RE, Lee PP, Agardh CD, Davis M, et al. Representing the Global Diabetic Retinopathy Project Group. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology. 2003;110:1677-82.
11. Photocoagulation for diabetic macular edema. Early treatment diabetic retinopathy study report number 1. Early treatment diabetic retinopathy Study research group. Arch Ophthalmol. 1985;103:1796-806.
12. IDF Diabetes Atlas. Available from http://www.idf.org/diabetesatlas. Accessed 1 July 2015.
13. Schellini SA, Carvalho GM, Rendeiro FS, Padovani CR, Hirai FE. Prevalence of diabetes and diabetic retinopathy in a Brazilian population. Ophthalmic Epidemiol. 2014;21:33-8.
14. Jost BS, Hilgemberg E, Rodrigues EB, Daniotti AF, Bonamigo EL. Prevalence of diabetic retinopathy in patients affected by type 2 diabetes mellitus in the city of Luzerna - SC. Arq Bras Oftalmol. 2010;73:259-65.
15. Escarião PHG, Arantes TEF, Figueiroa Filho NC, Urtiga RD, Florêncio TLT, Arcoverde ALAL. Epidemiology and regional differences of diabetic retinopathy in Pernambuco. Brazil. Arq Bras Oftalmol. 2008;71:172-5.
16. Guedes MF, Portes AJF, Couto Junior AS, Nunes JS, Oliveira RCC. Prevalence of the diabetic retinopathy in a Family's Health Program unity. Rev Bras Oftalmol. 2009;68:90-5.
17. Souza EV, Souza NV, Rodrigues MLV. Diabetic retinopathy among patients assisted by a multidisciplinary program at the University Hospital of Ribeirão Preto, São Paulo - USP. Arq Bras Oftalmol. 2004;67:433-6.
18. Esteves JF, Kramer CK, Azevedo MJ, Stolz AP, Roggia MF, Larangeira A, et al. Prevalence of diabetic retinopathy in patients with type 1 diabetes mellitus. Rev Assoc Med Bras. 2009;55:268-73.
19. Ramos SR, Sabbag FP, Busato D, Miranda AB, Moreira Júnior CA. Diabetic retinopathy: study from a Diabetic Association. Arq Bras Oftal. 1999;62:735-7.
20. American Diabetes Association. Standards of medical care 2014. Diabetes Care. 2014;37(Suppl):1.
21. Olson JA, Strachan FM, Hipwell JH, Goatman KA, McHardy KC, Forrester JV, et al. A comparative evaluation of digital imaging, retinal photography and optometrist examination in screening for diabetic retinopathy. Diabet Med. 2003;20:528-34.
22. Philip S, Fleming AD, Goatman KA, Fonseca S, McNamee P, Scotland GS, et al. The efficacy of automated ''disease/no disease'' grading for diabetic retinopathy in a systematic screening programme. Br J Ophthalmol. 2007;91:1512-7.
23. Kraemer HC, Periyakoil VS, Noda A. Tutorial in biostatistics. Kappa coefficients in medical research. Statist Med. 2002;21:2109-29.
24. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159-74.
25. Siegel S, Castellan NJ. Nonparametric statistics. 2nd ed. New York: McGraw-Hill; 1988.
26. Pereira JCR. Bioestatística em outras palavras. 1st ed. São Paulo: EDUSP, FAPESP; 2010.
27. Fleiss JL, Levin B, Paik MC. Statistical methods for rates and proportions. 3rd ed. London: Wiley; 2003.
28. Murgatroyd H, Ellingford A, Cox A, Binnie M, Ellis JD, MacEwen CJ, et al. Effect of mydriasis and different field strategies on digital image screening of diabetic eye disease. Br J Ophthalmol. 2004;88:920-4.
29. Herbert HM, Jordan K, Flanagan DW. Is screening with digital imaging using one retinal view adequate? Eye. 2003;17:497-500.
30. Shi L, Wu H, Dong J, Jiang K, Lu X, Shi J. Telemedicine for detecting diabetic retinopathy: a systematic review and meta-analysis. Br J Ophthalmol. 2015;99:823-31.
31. Soliman AZ, Silva PS, Aiello LP, Sun JK. Ultra-wide field retinal imaging in detection, classification, and management of diabetic retinopathy. Semin Ophthalmol. 2012;27:221-7.
32. Witmer MT, Kiss S. Wide-field imaging of the retina. Surv Ophthalmol. 2013;58:143-54.
33. Silva PS, Cavallerano JD, Tolson AM, Rodriguez J, Rodriguez S, Ajlan R, et al. Real-time ultrawide field image evaluation of retinopathy in a diabetes telemedicine program. Diabetes Care. 2015;38:1643-9.
34. Kinyoun JL, Martin DC, Fujimoto WY, Leonetti DL. Ophthalmoscopy versus fundus photographs for detecting and grading diabetic retinopathy. Invest Ophthalmol Vis Sci. 1992;33:1888-93.
35. Kernt M, Hadi I, Pinter F, Seidensticker F, Hirneiss C, Haritoglou C, et al. Assessment of diabetic retinopathy using nonmydriatic ultra-widefield scanning laser ophthalmoscopy (Optomap) compared with ETDRS 7-field stereo photography. Diabetes Care. 2012;35:2459-63.
36. Liesenfeld B, Kohner E, Piehlmeier W, Kluthe S, Aldington S, Porta M, et al. A telemedical approach to the screening of diabetic retinopathy: digital fundus photography. Diabetes Care. 2000;23:345-8.
37. Tran THC, Rahmoun J, Hui Bon Hoa AA. Screening for diabetic retinopathy using a three-field digital nonmydriatic fundus camera in the North of France. J Français d'ophthalmologie. 2009;32:735-41.
38. Li HK, Danis RP, Hubbard LD, Florez-Arango JF, Esquivel A, Krupinski EA. Comparability of digital photography with the ETDRS film protocol for evaluation of diabetic retinopathy severity. Invest Ophthalmol Vis Sci. 2011;52:4717-25.
39. Lin DY, Blumenkranz MS, Brothers RJ, Grosvenor DM. The sensitivity and specificity of single-field nonmydriatic monochromatic digital fundus photography with remote image interpretation for diabetic retinopathy screening: a comparison with ophthalmoscopy and standardized mydriatic color photography. Am J Ophthalmol. 2002;134:204-13.
40. Ogunyemi O, Moran E, Patty Daskivich L, George S, Teklehaimanot S, Ilapakurthi R, et al. Autonomy versus automation: perceptions of nonmydriatic camera choice for teleretinal screening in an urban safety net clinic. Telemed J E Health. 2013;19:591-6.
41. Jonas JB, Xu L. Histological changes of high axial myopia. Eye. 2014;28:113-7.
42. Looker HC, Nyangoma SO, Cromie D, Olson JA, Leese GP, Black M, et al. On behalf of the Scottish Diabetic Retinopathy Screening Collaborative and the Scottish Diabetes Research Network Epidemiology Group. Diabetic retinopathy at diagnosis of type 2 diabetes in Scotland. Diabetologia. 2012;55:2335-42.
43. Silva PS, Aiello LP. Telemedicine and eye examinations for diabetic retinopathy. A time to maximize real-world outcomes. JAMA Ophthalmol. 2015;133:525-6.
44. Zimmer-Galler IE, Kimura AE, Gupta S. Diabetic retinopathy screening and the use of telemedicine. Curr Opin Ophthalmol. 2015;26:167-72.
45. Mansberger SL, Sheppler C, Barker G, Gardiner SK, Demirel S, Wooten K, et al. Long-term comparative effectiveness of telemedicine in providing diabetic retinopathy screening examinations: a randomized clinical trial. JAMA Ophthalmol. 2015;133:518-25.